Literature DB >> 29936330

Walking ability, anxiety and depression, significantly decrease EuroQol 5-Dimension 5-Level scores in older hemodialysis patients in Japan.

Utako Shimizu1, Hagiko Aoki2, Momoe Sakagami3, Kohei Akazawa4.   

Abstract

BACKGROUND: Hemodialysis patients in Japan are aging, but the influence of lifestyle factors on EuroQoL 5-Dimension 5-Level (EQ-5D-5 L) scores in older hemodialysis patients is unclear. This study aimed to measure health-related quality of life using the EQ-5D-5 L for older hemodialysis patients and to identify the lifestyle factors affecting EQ-5D-5 L scores in Japan.
METHODS: Outpatients aged 65 years or older who had been receiving maintenance hemodialysis for more than 5 years were selected to determine their EQ-5D-5 L scores. Multiple linear regression analysis was applied to identify items affecting the EQ-5D-5 L scores.
RESULTS: The response rate was 59.7% (748/1251), after excluding 9 patients who did not fulfill the participation criteria, and we analyzed data from 739 patients (462 men, 277 women) aged 72.9 ± 6.5 years (mean ± standard deviation) with a mean duration of hemodialysis of 15.1 ± 8.8 years. The mean EQ-5D-5 L score was 0.738 ± 0.207. Higher Hospital Anxiety and Depression Scale scores (regression coefficient, -0.467; P < 0.001), reduced walking ability (-0.201; P < 0.001), duration of hemodialysis (-0.175; P < 0.001), age (-0.143; P < 0.001), and subjective symptoms (-0.128; P < 0.001) showed significant negative correlations with the EQ-5D-5 L score.
CONCLUSIONS: Reduced walking ability, and Anxiety and Depression, were associated with lower EQ-5D-5 L score and appeared to be important factors in decreasing health for older hemodialysis patients. These results suggest that patients' families and dialysis facility staff should be trained in early detection of depression and that patients should maintain their walking ability by exercise therapy.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  EQ-5D-5L; Health utility; Hemodialysis; Older

Mesh:

Year:  2018        PMID: 29936330     DOI: 10.1016/j.archger.2018.06.006

Source DB:  PubMed          Journal:  Arch Gerontol Geriatr        ISSN: 0167-4943            Impact factor:   3.250


  5 in total

1.  The cross-lagged association between depressive symptoms and health-related quality of life in patients receiving maintenance hemodialysis: a three-wave longitudinal study.

Authors:  Jieling Chen; Lingling Liu; Jing Chen; Marques S N Ng; Vivian W Q Lou; Bibo Wu; Weijie Jiang; Yanqing Jie; Jingfen Zhu; Yaping He
Journal:  Qual Life Res       Date:  2021-05-11       Impact factor: 4.147

2.  Evaluation of the construct reliability and validity of the DSM-5 Self-Rated Level 1 Cross-Cutting Symptom Measure-Chinese version in maintenance hemodialysis patients.

Authors:  Shao-Jun Ma; Wen-Ji Wang; Min Tang; Han Chen; Feng Ding
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

3.  Factors affecting health-related quality of life in older patients with chronic kidney disease: a single-center cross-sectional study.

Authors:  Aki Tabata; Hiroki Yabe; Takehide Katogi; Tomoya Yamaguchi; Yuya Mitake; Oono Shunta; Tomohiro Shirai; Takayuki Fujii
Journal:  Int Urol Nephrol       Date:  2022-03-25       Impact factor: 2.266

4.  Biomarkers for assessing acute kidney injury for people who are being considered for admission to critical care: a systematic review and cost-effectiveness analysis.

Authors:  Miriam Brazzelli; Lorna Aucott; Magaly Aceves-Martins; Clare Robertson; Elisabet Jacobsen; Mari Imamura; Amudha Poobalan; Paul Manson; Graham Scotland; Callum Kaye; Simon Sawhney; Dwayne Boyers
Journal:  Health Technol Assess       Date:  2022-01       Impact factor: 4.106

5.  The impact of pain on the quality of life of patients with end-stage renal disease undergoing hemodialysis: a multicenter cross-sectional study from Palestine.

Authors:  Aseel F Samoudi; Maha K Marzouq; Ahmad M Samara; Sa'ed H Zyoud; Samah W Al-Jabi
Journal:  Health Qual Life Outcomes       Date:  2021-02-02       Impact factor: 3.186

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.